Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'POSSIBLE LINK' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 25 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Colwell, JA
      Treatment for the procoagulant state in type 2 diabetes

      ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
    2. Koistinen, HA; Dusserre, E; Ebeling, P; Vallier, P; Koivisto, VA; Vidal, H
      Subcutaneous adipose tissue expression of plasminogen activator inhibitor-1 (PAI-1) in nondiabetic and Type 2 diabetic subjects

      DIABETES-METABOLISM RESEARCH AND REVIEWS
    3. Morange, PE; Lijnen, HR; Alessi, MC; Kopp, F; Collen, D; Juhan-Vague, I
      Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    4. MacLean, PS; Bower, JF; Vadlamudi, S; Green, T; Barakat, HA
      Lipoprotein subpopulation distributions in lean, obese, and type 2 diabetic women: A comparison of African and white Americans

      OBESITY RESEARCH
    5. Wick, G
      Atherosclerosis - An autoimmune disease due to an immune reaction against heat-shock protein 60

      HERZ
    6. Valle, M; Gascon, F; Martos, R; Ruz, FJ; Bermudo, F; Rios, R; Canete, R
      Infantile obesity: A situation of atherothrombotic risk?

      METABOLISM-CLINICAL AND EXPERIMENTAL
    7. Kruszynska, YT; Yu, JG; Olefsky, JM; Sobel, BE
      Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects

      DIABETES
    8. Crandall, DL; Groeling, TM; Busler, DE; Antrilli, TM
      Release of PAI-1 by human preadipocytes and adipocytes independent of insulin and IGF-1

      BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    9. Nilsson, L; Takemura, T; Eriksson, P; Hamsten, A
      Effects of fibrate compounds on expression of plasminogen activator inhibitor-1 by cultured endothelial cells

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    10. Mavri, A; Stegnar, M; Krebs, M; Sentocnik, JT; Geiger, M; Binder, BR
      Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    11. Festa, A; D'Agostino, R; Mykkanen, L; Tracy, R; Howard, BV; Haffner, SM
      Low-density lipoprotein particle size is inversely related to plasminogen activator inhibitor-1 levels - The Insulin Resistance Atherosclerosis Study

      ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    12. Harko, T; Mak, MK
      Particle creation in varying speed of light cosmological models

      CLASSICAL AND QUANTUM GRAVITY
    13. Harko, T; Mak, MK
      Anisotropic homogeneous universes in the varying speed of light theory

      INTERNATIONAL JOURNAL OF MODERN PHYSICS D
    14. Despres, JP
      Insulin resistance and hyperglycemic associated risk factors - Session summary

      DIABETES CARE
    15. Crandall, DL; Quinet, EM; Morgan, GA; Busler, DE; McHendry-Rinde, B; Kral, JG
      Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes

      JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
    16. Harko, T; Mak, MK
      Particle creation in cosmological models with varying gravitational and cosmological "constants"

      GENERAL RELATIVITY AND GRAVITATION
    17. GALAJDA P; BALAZ D; MARTINKA E; MOKAN M; KUBISZ P
      INSULIN-TREATMENT INHIBITS PAI-1 PRODUCTION IN NIDDM PATIENTS WITH ENDOTHELIAL DYSFUNCTION

      Clinical and applied thrombosis/hemostasis
    18. RIOS MS
      RELATIONSHIP BETWEEN OBESITY AND THE INCREASED RISK OF MAJOR COMPLICATIONS IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS

      European journal of clinical investigation
    19. ABDUSSATTAR; VISHWAKARMA RG
      SOME FRW MODELS WITH VARIABLE-G AND VARIABLE-LAMBDA

      Classical and quantum gravity
    20. FRIEDLANDER Y; ELKANA Y; SINNREICH R; KARK JD
      GENETIC AND ENVIRONMENTAL SOURCES OF FIBRINOGEN VARIABILITY IN ISRAELI FAMILIES - THE KIBBUTZIM FAMILY STUDY

      American journal of human genetics
    21. KALLIGAS D; WESSON PS; EVERITT CWF
      BIANCHI TYPE-I COSMOLOGICAL MODELS WITH VARIABLE-G AND VARIABLE-LAMBDA - A COMMENT

      General relativity and gravitation
    22. HAMSTEN A; STEINER G
      NON-INSULIN-DEPENDENT DIABETES-MELLITUS AND ATHEROSCLEROSIS - A LIPOPROTEIN PERSPECTIVE

      Journal of internal medicine
    23. MASSA C
      IMPLICATIONS OF A COSMOLOGICAL TERM COUPLED TO MATTER

      Astrophysics and space science
    24. BEESHAM A
      BIANCHI TYPE-I COSMOLOGICAL MODELS WITH VARIABLE-G AND LAMBDA

      General relativity and gravitation
    25. WILSON TW; KAPLAN GA; KAUHANEN J; COHEN RD; WU M; SALONEN R; SALONEN JT
      ASSOCIATION BETWEEN PLASMA-FIBRINOGEN CONCENTRATION AND 5 SOCIOECONOMIC INDEXES IN THE KUOPIO ISCHEMIC-HEART-DISEASE RISK FACTOR STUDY

      American journal of epidemiology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 03:47:54